SUPN
Supernus Pharmaceuticals Inc.
$48.87
-$0.13(-0.28%)
73
Overall
65
Value
90
Tech
65
Quality
Market Cap
$2.58B
Volume
414.97K
52W Range
$29.16 - $51.78
Target Price
$54.20
Key Metrics Overview
| Market Cap | $2.58B | P/E Ratio | 28.91 |
| 52W High | $51.78 | 52W Low | $29.16 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 9.9% | 52W Position | 87.1% |
| Overall Score | 73 | Value Score | 65 |
| Quality Score | 65 | Technical Score | 90 |
Growth Analysis
| EPS Current Est | $1.69 | EPS Next Est | $2.14 |
| EPS Growth Est | +26.6% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SUPN | $48.87 | -0.3% | 414.97K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Supernus Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW